103 related articles for article (PubMed ID: 12855989)
21. Bilateral anterior uveitis associated with travoprost.
Suominen S; Välimäki J
Acta Ophthalmol Scand; 2006 Apr; 84(2):275-6. PubMed ID: 16637856
[No Abstract] [Full Text] [Related]
22. Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.
Stewart WC; Stewart JA; Day DG; Sharpe ED; Jenkins JN
Eye (Lond); 2004 Oct; 18(10):990-5. PubMed ID: 15037890
[TBL] [Abstract][Full Text] [Related]
23. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
24. Alphagan allergy may increase the propensity for multiple eye-drop allergy.
Osborne SA; Montgomery DM; Morris D; McKay IC
Eye (Lond); 2005 Feb; 19(2):129-37. PubMed ID: 15254495
[TBL] [Abstract][Full Text] [Related]
25. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
[TBL] [Abstract][Full Text] [Related]
26. Metipranolol-associated nongranulomatous anterior uveitis.
Patel NP; Patel KH; Moster MR; Spaeth GL
Am J Ophthalmol; 1997 Jun; 123(6):843-4. PubMed ID: 9535634
[TBL] [Abstract][Full Text] [Related]
27. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
[TBL] [Abstract][Full Text] [Related]
28. Metipranolol-associated granulomatous iritis.
Melles RB; Wong IG
Am J Ophthalmol; 1994 Dec; 118(6):712-5. PubMed ID: 7977597
[TBL] [Abstract][Full Text] [Related]
29. Bilateral anterior uveitis associated with 0.3% minims metipranolol.
Kamalarajah S; Johnston PB
Eye (Lond); 1999 Jun; 13 ( Pt 3a)():380-1. PubMed ID: 10624443
[No Abstract] [Full Text] [Related]
30. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
Hernández M; Urcola JH; Vecino E
Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
[TBL] [Abstract][Full Text] [Related]
31. Corneal oedema and acute anterior uveitis after two doses of travoprost.
Aydin S; Ozcura F
Acta Ophthalmol Scand; 2007 Sep; 85(6):693-4. PubMed ID: 17403018
[No Abstract] [Full Text] [Related]
32. Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination.
Akman A; Cetinkaya A; Akova YA; Ertan A
Eye (Lond); 2005 Feb; 19(2):145-51. PubMed ID: 15184958
[TBL] [Abstract][Full Text] [Related]
33. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
Chen TC
J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
[TBL] [Abstract][Full Text] [Related]
34. Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children.
Bowman RJ; Cope J; Nischal KK
Eye (Lond); 2004 Jan; 18(1):24-6. PubMed ID: 14707960
[TBL] [Abstract][Full Text] [Related]
35. Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema?
Chang JH; McCluskey P; Missotten T; Ferrante P; Jalaludin B; Lightman S
Br J Ophthalmol; 2008 Jul; 92(7):916-21. PubMed ID: 18460537
[TBL] [Abstract][Full Text] [Related]
36. Granulomatous uveitis and metipranolol.
O'Connor GR
Br J Ophthalmol; 1993 Aug; 77(8):536-8. PubMed ID: 7912953
[No Abstract] [Full Text] [Related]
37. Brimonidine tartarate 0.2% (Alphagan) associated granulomatous anterior uveitis.
Goyal R; Ram AR
Eye (Lond); 2000 Dec; 14(Pt 6):908-10. PubMed ID: 11584856
[No Abstract] [Full Text] [Related]
38. Drug-induced ectropion: what is best practice?
Hegde V; Robinson R; Dean F; Mulvihill HA; Ahluwalia H
Ophthalmology; 2007 Feb; 114(2):362-6. PubMed ID: 17270684
[TBL] [Abstract][Full Text] [Related]
39. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma.
Nagar M; Ogunyomade A; O'Brart DP; Howes F; Marshall J
Br J Ophthalmol; 2005 Nov; 89(11):1413-7. PubMed ID: 16234442
[TBL] [Abstract][Full Text] [Related]
40. Topical glaucoma therapy as a risk factor for nasolacrimal duct obstruction.
Seider N; Miller B; Beiran I
Am J Ophthalmol; 2008 Jan; 145(1):120-123. PubMed ID: 17915187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
